COMPOUNDS, AND COMPOSITIONS THEREOF, WHICH MODULATE PYRUVATE KINASE M2, AND METHODS OF MAKING SAME
Compounds of formula (I) that modulate pyruvate kinase M2 (PKM2) and pharmaceutically acceptable salts thereof, and compositions comprising compounds of formula (I) that modulate PKM2 and pharmaceutically acceptable salts thereof, are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of a disease or disorder related to PKM2 function selected from the group consisting of a cancer, obesity, diabetes, atherosclerosis, restenosis and autoimmune diseases..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 22. Aug. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
SAUNDERS JEFFREY O [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-08-22, Last update posted on www.tib.eu: 2024-04-15, Last updated: 2024-04-19 |
|---|
| Patentnummer: |
CA2944788 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA003494756 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA003494756 | ||
| 003 | DE-627 | ||
| 005 | 20240419121336.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240419s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA003494756 | ||
| 035 | |a (EPA)CA2944788 | ||
| 035 | |a (EPA)43381412 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a SAUNDERS JEFFREY O |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COMPOUNDS, AND COMPOSITIONS THEREOF, WHICH MODULATE PYRUVATE KINASE M2, AND METHODS OF MAKING SAME |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-08-22, Last update posted on www.tib.eu: 2024-04-15, Last updated: 2024-04-19 | ||
| 520 | |a Compounds of formula (I) that modulate pyruvate kinase M2 (PKM2) and pharmaceutically acceptable salts thereof, and compositions comprising compounds of formula (I) that modulate PKM2 and pharmaceutically acceptable salts thereof, are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of a disease or disorder related to PKM2 function selected from the group consisting of a cancer, obesity, diabetes, atherosclerosis, restenosis and autoimmune diseases. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a SALITURO FRANCESCO G |e verfasserin |4 aut | |
| 700 | 0 | |a YAN SHUNQI |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 22. Aug. |
| 773 | 1 | 8 | |g year:2023 |g day:22 |g month:08 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/43381412/publication/CA2944788A1?q=CA2944788 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 22 |c 08 | ||